Good observation. With dosing completed in the UK Parkinson...

  1. 8 Posts.
    lightbulb Created with Sketch. 2
    Good observation. With dosing completed in the UK Parkinson Trial, more updates would be expected. If SNT 5505 demonstrates strong Phase II results, early equity positioning by Big Pharma makes sense to secure exclusivity and reduce competition. Looking forward to more clarity from the company. Great opportunity to buy more currently!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.0¢
Change
-0.004(6.60%)
Mkt cap ! $80.43M
Open High Low Value Volume
5.3¢ 5.3¢ 4.9¢ $347.4K 6.947M

Buyers (Bids)

No. Vol. Price($)
4 664323 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 90737 4
View Market Depth
Last trade - 15.12pm 20/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.